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Abstract
Background
Agreed international development standards underpin high quality de novo clinical practice
guidelines (CPGs). There is however, no international consensus on how high quality CPGs
should ‘look’; or on whether high quality CPGs from one country can be viably implemented
elsewhere. Writing de novo CPGs is generally resource-intensive and expensive, making
this challenging in resource-poor environments. This paper proposes an alternative, efficient
method of producing high quality CPGs in such circumstances, using existing CPGs layered
by local knowledge, contexts and products.
Methods
We undertook a mixed methods case study in South African (SA) primary healthcare (PHC),
building on findings from four independent studies. These comprised an overview of interna-
tional CPG activities; a rapid literature review on international CPG development practices;
critical appraisal of 16 purposively-sampled SA PHC CPGs; and additional interrogation of
these CPGs regarding how, why and for whom, they had been produced, and how they
‘looked’.
Results
Despite a common aim to improve SA PHC healthcare practices, the included CPGs had dif-
ferent, unclear and inconsistent production processes, terminology and evidence presenta-
tion styles. None aligned with international quality standards. However many included
innovative succinct guidance for end-users (which we classified as evidence-based sum-
mary recommendations, patient management tools or protocols). We developed a three-
tiered model, a checklist and a glossary of common terms, for more efficient future produc-
tion of better quality, contextually-relevant, locally-implementable SA PHC CPGs. Tier 1
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involves transparent synthesis of existing high quality CPG recommendations; Tier 2
reflects local expertise to layer Tier 1 evidence with local contexts; and Tier 3 comprises tai-
lored locally-relevant end-user guidance.
Conclusion
Our model could be relevant for any resource-poor environment. It should reduce effort and
costs in finding and synthesising available research evidence, whilst efficiently focusing
scant resources on contextually-relevant evidence-based guidance, and implementation.
Background
The theory and practice of clinical practice guideline (CPG) writing has evolved over the past
35 years. This reflects growing sophistication in clinical epidemiology, technical writing and
application of new technologies to evidence synthesis. Changing CPG definitions over this
time period highlight this evolution. The Institute of Medicine (IOM) described CPGs in 1990
as ‘systematically developed statements to assist practitioner and patient decisions about appro-
priate health care for specific clinical circumstances’http://ebn.bmj.com/content/2/2/38.full—
ref-1 (p. 38) [1]. This definition was updated in 2011 to emphasise the importance of rigorous
methodology, suggesting that ‘Clinical guidelines are statements that include recommendations
intended to optimize patient care that are informed by a systematic review of evidence and an
assessment of the benefits and harms of alternative care options’ (p. 15) [2]. The current CPG
definition focuses on implementation, stating that ‘Guidelines are a convenient way of packag-
ing evidence and presenting recommendations to healthcare decision makers‘ (p. 6) [3].
Over the past 35 years, internationally-respected CPG development groups have been estab-
lished, such as (but not limited to) National Institute for Health and Care Excellence (NICE)
[4] and the Scottish Intercollegiate Guidelines Network (SIGN) [5]. These groups regularly
produce CPGs for a wide range of topics and health conditions. There are also internationally-
respected internet-based repositories of CPGs, such as the USA Agency for Healthcare
Research and Quality (AHRQ) Guidelines Clearing House [6], Guidelines International Net-
work (G-I-N) [7], and the World Health Organisation (WHO) [8]. Many professional associa-
tions also host CPGs on their websites or libraries. Consequently, it is not difficult to find
answers for most healthcare questions, from at least one international CPG repository.
However, the explosion of CPG activity internationally has led to lack of standardisation
about how CPGs are written and the evidence presented. Comparing two or more CPGs on
the same topic, even from respected international CPG developers, immediately highlights dif-
ferences [4–8]. Whilst this diversity is an enviable product of independent, international intel-
lectual endeavours in the area, it also makes it increasingly difficult for end-users to decide on
which CPGs to use. End-users can variably include healthcare providers, policy-makers, health
managers and planners, insurers and/ or patients. Rethinking CPG writing and presentation
to increase end-user uptake was a focus of the 2016 Guidelines International Network (G-I-N)
conference in Philadelphia, United States of America. There were many presentations about
making CPGs more relevant to end-users, and in believably presenting CPG recommenda-
tions in ways that encourage evidence uptake [9–11]. While there is now international consen-
sus on key quality components of CPGs [12–14], there is no international consensus on how
CPGs should ‘look’, as the term ‘CPG’ can refer to many different ways of presenting evidence
summaries.
A new way of considering clinical guidance
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In this paper, we describe steps we took to develop a theoretical model aimed at efficiently
improving the quality and uptake of contextually-relevant CPGs. Our research grew from a
commitment to improve CPG quality, relevance and uptake in environments with limited
resources for de novo (new) CPG writing. This research focused on South African (SA) pri-
mary healthcare (PHC). Resources for SA CPG writing and evidence implementation have
been constrained for three decades, despite the escalating and currently-unmet need for best-
evidenced, standardised guidance to redress the increasing prevalence of communicable and
non-communicable diseases [15–17]. It is thus essential that scant health resources are put to
best use to efficiently implement best available, locally-relevant evidence into SA PHC
practices.
PHC became a SA government priority in the 1994 National Health Plan [18, 19]. PHC pro-
viders (GPs, nurses, allied health practitioners) care for South Africans over their lifespan, with
PHC being the usual point of entry into the SA healthcare system [15, 17]. In SA, clinical guid-
ance for PHC conditions has been developed independently by different groups, including the
National and Provincial Departments of Health at district and facility levels, and by profes-
sional societies [20]. There is no central, nationally-recognized and/ or accepted CPG develop-
ment unit. Given the escalating numbers of South Africans requiring PHC for increasingly
complex, comorbid health conditions [15–19], it is imperative that SA PHC providers are con-
versant with, and able to access and apply, current best evidence to diagnose and care for the
patients presenting at PHC facilities [21].
Methods
Ethics approval
Ethics approval was provided by the South African Medical Research Council (HREC EC002-
2/3014).
Purpose
To produce a simple theoretical model to underpin the efficient production of contextually-
relevant good quality CPGs for resource-constrained environments.
Model development strategy
To identify and address gaps between international CPG standards, and the way evidence was
presented in SA PHC CPGs, whilst recognising and addressing local contexts, implementation
barriers and end-user needs [15–19].
Research design
We conducted a mixed methods case study [22, 23] which amalgamated findings from four
independent studies conducted as part of a large research project into SA PHC CPGs (Project
SAGE (South African Guidelines Excellence)) [24]. The Good Reporting of A Mixed Methods
Study (GRAMMS) reporting framework guided the research [25]. S1 Appendix outlines how
our research met the GRAMMS reporting criteria. Fig 1 describes the case study approach.
In Study 1 (conducted October 2014- January 2015), we deconstructed the ‘mysteries’ of
international CPG activities and nomenclature to establish a comprehensive current ‘state of
play’ [26]. Study 1 set the scene for Project SAGE by describing the complexities of writing and
implementing good quality, locally-relevant CPGs [24]. Study 1 comprised a content review of
documents (and their references lists), found on publically-available international CPG web-
sites [4–8]. We reviewed reports, publications, blogs, podcasts and interviews, conference
A new way of considering clinical guidance
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presentations and position statements. Using content analysis, we identified themes, gaps in
activity, quality measures and current theory and practice in CPG writing.
In Study 2 (conducted December 2014- March 2015), we undertook a systematic rapid
review of English language literature reporting on methods of CPG development [27]. The
search was conducted from January 1st, 1990 to December 31st, 2014, to include publications
since the IOM CPG definition was proposed [1]. Databases covering health and social sciences
literature and grey literature were searched, comprising Biomed Central Gateway; CINAHL
database; Cochrane Library; EMBASE; ERIC; Health Source (Nursing / Academic Edition);
PsychInfo; Scopus; Web of Knowledge; World Health Organisation (WHO); Scottish In-
tercollegiate Guidelines Network (SIGN); National Guideline Clearinghouse (NGC); UK
Fig 1. Case study approach.
https://doi.org/10.1371/journal.pone.0195025.g001
A new way of considering clinical guidance
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Department of Health publications; UK National Institute for Health and Clinical Excellence
Guidelines (NICE); and Google Scholar. Search terms were customised to each database, and
included synonyms of ‘CPGs’, ‘development’ and ‘methodological quality’. The Medline search
strategy and ‘hits’ are provided in S2 Appendix as an example. In line with rapid review prac-
tices, we sought current systematic reviews as the best available evidence, and assessed their
quality with the Critical Appraisal Skills Program (CASP) systematic review tool [28, 29].
In Study 3 (February 2015- April 2015), we used the AGREE II instrument (Appraisal of
Guidelines for Research and Evaluation) to assess the methodological quality of 16 purpo-
sively-sampled SA PHC CPGs [30]. AGREE II is an internationally-accepted critical appraisal
tool for researchers and developers, which assesses CPG quality in domains of CPG scope and
purpose, stakeholder involvement, rigour of development, clarity of presentation, applicability
of the CPG to its intended setting, and editorial independence [13]. The selected CPGs
included documents produced in SA, outlining diagnosis, treatment, and/or clinical manage-
ment of commonly-presenting conditions in SA PHC settings [15, 17, 19]. These comprised
asthma, chronic obstructive pulmonary disease (COPD), hypertension, Type 2 diabetes,
human immune-deficiency syndrome (HIV) (children, adults, prevention of mother-to-child
transmission (PMTCT)), tuberculosis (TB), malaria, maternal care, Primary Care (PC 101)
and integrated management of childhood illnesses (IMCI). We also included the Essential
Drug List (EDL) which is used by SA healthcare providers to guide medicines choice.
For Study 4, we extracted and collated further details from the Study 3 CPGs [30], regarding
who developed and published them, how the evidence was reported, who the end-users were,
the CPG scope, purpose and aims, and the ways in which guidance was presented.
Data analysis
For Studies 3 and 4, the AGREE II methodological quality scores were calculated as:
• median and interquartile ranges (IQR) for the six quality domains across the 16 CPGs; and
• overall quality scores for each CPG. This calculation was undertaken by adjusting the
AGREE II domain scoring rubric to include all 23 AGREE II items. Whilst this is not the
usual AGREE II scoring approach [13], it provided an overall estimate of methodological
quality for comparison across the CPGs.
The findings from Studies 3 and 4 were compared with international CPG terminology and
production methods (Studies 1 and 2), to identify gaps, possible reasons for them, and solu-
tions to improve SA PHC CPG quality.
Results
Study 1
Our summary of the current ‘state of play’ of international CPG activity highlighted not only
variability in CPG writing processes and terminology, but also fragmentation in how informa-
tion was reported [26]. This highlighted the emphasis internationally on CPG development,
and identified research gaps in evidence updating, as well as ways of transferring evidence
developed in one setting to different settings. We identified the difficulty that inexperienced
CPG writers and end-users might have, in understanding and applying current CPG writing
processes and terminology in their own contexts. This relates to confusion surrounding the
terminology and construction methods for CPGs; variable ways in which evidence is reported
and recommendations framed; how to deal with inconsistent evidence and its interpretation;
and presentation of end-user guidance.
A new way of considering clinical guidance
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Study 2
The rapid literature review identified 1501 potentially-relevant records (1355 after removal of
duplicates). After screening for relevance, 83 potentially-relevant records were considered in
full text. These included one recent comprehensive systematic literature review (102 refer-
ences) [14], and 82 primary literature and grey literature sources (comprising observational
and descriptive studies, and guideline development manuals). The systematic review [14]
scored 92% for methodological quality [29, 31], and was thus deemed to be the best available
evidence [28]. It included 80 of the 82 identified primary evidence sources. The two not-
included articles were published in the 1990s, and their exclusion was unlikely to have influ-
enced the systematic review findings. The systematic literature review proposed 18 domains of
quality construction, with the domains 8, 10, 11, 12, 13 and 14 focusing on the methodology of
a good quality CPG [14]. These are bolded in the list below. The quality domains comprise 1.
organisation, budget, planning and training; 2. priority setting; 3. guideline group member-
ship; 4. establishing guideline group processes; 5. identifying target audience and topic selec-
tion; 6. consumer and stakeholder involvement; 7. conflict of interest considerations; 8.
question generation; 9. considering importance of outcomes and interventions, values, prefer-
ences and utilities; 10. deciding what evidence to include and searching for evidence; 11.
summarising evidence and considering additional information; 12. judging quality,
strength of certainty of a body of evidence; 13. developing recommendations and deter-
mining their strength; 14. wording of recommendations and considerations about imple-
mentation, feasibility and equity; 15. reporting and peer-review; 16. dissemination and
implementation; 17. evaluation and use; 18. updating [14].
Study 3
Whilst the SA PHC guidance documents were labelled ‘CPGs’, they had variable and generally
low scores in the AGREE II methodological quality domains [30], and none looked similar to
CPGs produced by international developers [4,5]. Considering the median (IQR) AGREE II
domain scores across the 16 included CPGs, the domains with highest scores were clarity of
presentation (69% (44–94%)); and scope and purpose (55% (19–92%)). The remaining
domains scored poorly (stakeholder involvement (22% (0–64%)); applicability (13% (0–83%));
rigour of development (4% (0–30)); and editorial independence (0% (0–29%)). These findings
differed little from an earlier review of the methodological quality of CPGs produced in
selected African countries for five priority diseases [31], suggesting that SA CPGs generally
compared poorly with international CPG quality construction indicators. Despite this, many
of the SA PHC CPGs contained innovative and contextually-relevant guidance. This poten-
tially reflected their common purpose of providing simple guidance for healthcare providers
to improve uptake of evidence into local PHC practices [15–17]. Thus rigour of development
and comprehensive reporting of CPG methodology may have been of less concern to the SA
PHC CPG writers, than providing easy-to-follow guidance about how care should be provided
to patients in PHC settings [27, 30].
Study 4
There was no standard approach to how the evidence underpinning the SA PHC CPG recom-
mendations had been identified, collated, evaluated or presented, and there was no evidence of
utility for end-users in PHC settings. Table 1 reports details on the CPG developers, where the
CPGs were located, their aim, their objective/ purpose, who identified and interpreted the evi-
dence (evidence funnel), how the CPGs were constructed (methods), and whether references
underpinned recommendations. Table 2 reports the intended end-users, the ways that the
A new way of considering clinical guidance
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evidence was presented, and the overall AGREE II score for each CPG. Only two CPGs scored
over 50% for overall methodological quality (Maternal Health 67%; PC101 58%).
Comparing SA CPGs with international quality practices
We first considered the content and quality of the five SA PHC CPGs developed by profes-
sional associations, and published in two peer-reviewed professional association journals (SA
Medical Journal (SAMJ) (2016–2017 impact factor 1.71) and Journal of Endocrinology,
Metabolism and Diabetes of SA (JEMDSA) (no current impact factor listed)). The CPGs dealt
with conditions of acute asthma in children (SAMJ), acute asthma in adults (SAMJ), COPD
(SAMJ), hypertension (SAMJ) and Type 2 diabetes (JEMDSA) (See Table 1). Compared with
Table 1. Summary of included SA PHC CPGs.
Developer Location found Stated
Aim
Evidence funnel Info on CPG
Methods
CPG Purpose / Objective References for
recommendations
Acute asthma in
children
Prof Ass Peer-reviewed local
journal
p
Specialist Experts
p
Standardise care
p
Acute asthma in adults Prof Ass Peer-reviewed local
journal
p
Specialist Experts
p
Standardise care
p
COPD Prof Ass Peer-reviewed local
journal
p
Specialist Experts
p
Standardise care
p
Hypertension Prof Ass Peer-reviewed local
journal
p
Specialist Experts NA Management
p
Type 2 diabetes Prof Ass Peer-reviewed local
journal
p
Specialist Experts NA Improve healthcare
delivery
p
EDL NDoH Government
publication
p
Specialist Experts NA Standardise practice NA
IMCI NDoH Government
publication
NA Badged WHO&,
UNICEF&&
NA Step-wise guide to
practice
p
(Presume WHO&
/UNICEF&& material)
Malaria prevention NDoH Government
publication
p
Experts NA Step-wise guide to
practice
p
Bibliography
Malaria treatment NDoH Government
publication
p
Experts NA Guide to risk assessment
and practice
p
Bibliography
Maternal care NDoH Government
publication
p
Expert NA Management
p
Available on request
TB in children NDoH Government
publication
p
NA NA Raise awareness NA
TB in adults NDoH Government
publication
p
NA NA Management NA
PC 101 (symptom
based guidance)
NDoH Government
publication
p
NA NA Standardise practices
p
Website for more
information
HIV in children NDoH Government
publication
p
NA NA Guidance NA
HIV adults NDoH Government
publication
p
NA NA Management NA
PMTCT (HIV) NDoH Government
publication
p
NA NA Guidance
p
Professional Association
NDOH–National Department of Health
& WHO—World Health Organisation
&& UNICEF—United Nations International Children’s Emergency Fund (better known now as United Nations Children’s Fund)
p
indicates this information was provided in the guidance document
NA indicates that this information was not available in the guidance document
https://doi.org/10.1371/journal.pone.0195025.t001
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the internationally-agreed elements of quality CPG construction (Studies 1 and 2 [14, 26]), these
CPGs variably reported on how they identified their evidence sources, how the quality, believabil-
ity and relevance of this evidence had been determined, how the recommendations they proposed
had been generated, or how the grades of evidence strength had been determined (when they
were reported). All five SA PHC CPGs included the names of contributors to CPG writing. They
also provided reference lists, however there was no indication of how and why these particular ref-
erences had been sourced, and not all recommendations were linked with references [13, 14].
Guidance was presented as text, summary recommendations and flowcharts.
We then considered the 11 CPGs which were developed and published by the SA National
Department of Health (NDoH), and compared these with international CPG practices. These
CPGs provided either condition-specific guidance (e.g. TB, HIV, malaria) or overall guidance
for multiple conditions (e.g. EDL, PC 101, IMCI). There was variable information provided on
the type and location of the evidence underpinning these CPGs, and no NDoH CPG outlined
an evidence searching or appraisal process. Only two CPGs provided the names of experts
involved in the writing. Guidance was presented as text, pictures, flow charts and/or decision-
making prompts.
Table 2. Intended end-users, evidence presentation and AGREE II overall scores.
End users Algorithm Description of
symptoms
Text-based
recommend-ations
Products Overall AGREE II
score (%)
Acute asthma
children
GP (private or public)
p

p
Evidence-based summary
recommendations
42
Acute asthma
adults
GP (private or public)
p p p
Evidence-based summary
recommendations
42
COPD GP (private or public)
p p
Evidence-based summary
recommendations
33
Hypertension GP (private or public)
p p p
Evidence-based summary
recommendations
50
Type 2 diabetes GP (private or public)
p
checklist
p p
Evidence-based summary
recommendations
33
EDL Primary care doctors and nurses
with prescribing rights
p p
Prescribing support
information
50
IMCI Frontline nurses / medics
p p p
Decision-support tool &
recommendations
42
Malaria
prevention
Frontline nurses / medics
p p
Recommendations 42
Malaria
treatment
All involved in management of
malaria
p p p
Decision-support tool &
recommendations
50
Maternal Frontline nurses/ medics
p p p
Decision-support tool &
recommendations
67
TB in children Frontline nurses / medics
p p p
Decision-support tool &
recommendations
33
TB in adults Professional health care workers
p p p
Decision-support tool &
recommendations
33
PC 101 Frontline nurses / medics
p p p
Decision-support tool &
recommendations
58
HIV in children Health practitioners
p p
Recommendations 42
HIV adults health practitioners
p p
Recommendations 33
PMTCT (HIV) Frontline nurses / medics
p p p
Decision-support tool &
Recommendations
42
GP–General medical Practitioner

p
indicates the types of evidence presentations in the guidance documents
https://doi.org/10.1371/journal.pone.0195025.t002
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Model construction
To address our purpose of improving efficient production of quality, locally-relevant CPGs in
SA, we then developed a theoretical three-tiered model from the case study findings, to bridge
the quality gaps between the SA PHC CPGs, and international CPG standards (Fig 2).
Tier 1 represents current, best-quality CPG recommendations, identified by systematic
international searches for relevant CPGs that meet international quality construction stan-
dards [12–14]. Tier 1 provides best available information on ‘what to do’. We propose that
without a robust Tier 1 underpinning it, no guidance document can legitimately be called a
CPG.
Tier 2 describes evidence input from local experts, to put Tier 1 recommendations into con-
text (‘how to do it locally’). This step potentially makes Tier 1 ‘what to do’ recommendations
relevant to local evidence implementation, end-user needs, indigenous healthcare cultures,
costs, feasibility, implementation barriers and patient engagement. Tier 2 draws on people
with intimate knowledge of local health systems, contexts and challenges, as well as barriers
and solutions to evidence implementation.
Tier 3 describes end-user guidance documents (evidence products to support ‘how to do
it’). These operationalise the findings of Tiers 1 and 2, and are written specifically to assist end-
users to implement evidence. Based on our case study findings, we propose a standard nomen-
clature for Tier 3 documents.
• Evidence-based Summary Recommendations. This term could be used where recommenda-
tions and explanatory text have been transparently extracted from good quality CPGs, lay-
ered with local contexts, and presented as resource material to support best-evidence
diagnosis and management of specific conditions in specific environments. These docu-
ments may also provide prompts for healthcare providers such as pictures and text descrip-
tions, summary recommendations for practice, checklists and/ or resource material. The SA
professional associations’ CPGs are best classified as evidence-based summary recommenda-
tions (see as an example the SA Hypertension Society CPG [32]).
• Patient Management Tools (PMTs). This describes patient management or decision-support
tools designed for situations where frontline healthcare professionals have to make explicit,
efficient and effective choices regarding diagnosis, immediate treatment and longer-term
management. PMTs could variably include pictures and simple explanatory text, algorithms
(‘if this, then do that’), symptom lists, management checklists, treatment choices and referral
pathways. Many NDoH CPGs were presented as PMTs. An example of a PMT is PC 101
[33].
Fig 2. Conceptual model to improve efficient production of quality, locally-relevant CPGs in SA.
https://doi.org/10.1371/journal.pone.0195025.g002
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• Protocols. Protocols provide step-by-step guidance on ‘how to do’ specific healthcare tasks
(taking bloods, resuscitation steps, diagnostic testing etc). Standard operating procedures
may also be called protocols. Protocols may be embedded in Evidence-based Summary Rec-
ommendations and PMTs. We propose that a guidance document could be called a ‘proto-
col’ when there is only one correct way to complete a task, and this can be outlined by a step-
by-step diagram or a series of text prompts.
Discussion
To the best of our knowledge, this paper presents the first theoretical model designed to assist
a resource-poor country to efficiently improve the quality of its CPGs.
The term ‘CPG’ is internationally recognised as referring to documents that meet interna-
tional quality construction elements [14] and score well on all AGREE II quality appraisal
domains [13]. On this basis, none of the included SA PHC CPGs should have been called
CPGs, as they were, at best, guidance documents, supported by variable underpinning evi-
dence. In many instances however, with little effort, the methodological quality (and hence
believability) of these guidance documents could have been readily improved, by using the
AGREE II principles as a construction framework. This would have prompted writers to
describe how the underpinning evidence sources had been identified and critically appraised,
and how recommendations were linked to references and strength of the body of evidence
statements.
We propose that investing effort in producing country- or organisation-specific de novo
CPGs (Tier 1) should be questioned in resource-constrained environments. The requisite rig-
orous evidence-searching required to establish Tier 1 is usually expensive and time-consuming
[4, 9, 21]. ‘Recreating the evidence wheel’ (developing a new Tier 1) is inefficient, when infor-
mation on ‘what to do’ is already available for many conditions, in current high quality CPGs
written by experienced CPG developers elsewhere [4–8, 12–14]. Embracing the notion of
‘adopting’ existing CPGs produced by well-resourced developers (Tier 1) would decrease the
impetus for resource-constrained countries or organisations to independently produce their
own CPGs which outline ‘what to do’. It particularly seems reasonable to propose that for con-
ditions where aetiology, symptoms and management are generally universal (such as asthma,
hypertension, COPD, diabetes, cancer, HIV, TB, maternal health conditions, and many infant
diseases), ‘what to do’ evidence from existing, current high quality CPGs could be readily
adopted as Tier 1 information in resource-constrained environments. The source (adopted)
CPGs should be referenced and cited appropriately [12–14], and the methods by which the
source CPGs had been identified, assessed and applied should be available to end-users if
required (e.g. on a freely-available website).
We further contend that the acknowledged CPG focus in resource-constrained environ-
ments should be on local implementation, and not evidence-construction. Thus by carefully
layering already available Tier 1 recommendations with expert input and local contexts, barri-
ers to evidence implementation could be efficiently identified and addressed (Tiers 2 and 3)
[15–19, 21, 34]. Our case study identified that important information is required to ensure the
credibility and transparency of the Tier 2 process. This includes contributors’ names and quali-
fications, how contributors were identified, their roles in producing the guidance document,
their professional affiliations, their conflicts of interest and how these were managed, and how
the Tier 2 discussions were managed [14, 30].
Based on our case study findings, Tier 3 documents should be viewed as evidence products,
as they are designed for specific purposes and end-users, aim to improve and standardise local
A new way of considering clinical guidance
PLOS ONE | https://doi.org/10.1371/journal.pone.0195025 March 30, 2018 10 / 14
healthcare practices, and be auditable. Many SA PHC CPGs provided innovative Tier 3 docu-
ments which succinctly presented evidence summaries for specific end-user needs, thus
providing step-by-step information on ‘how to locally apply’ Tier 1 ‘what to do’ recommenda-
tions. They provided a range of ways of fitting evidence to local contexts, cultures, practices
and settings, and they presented recommendations in ways that were simple, easy-to-read and
navigate. We believed that the SA PHC CPG Tier 3 products reflected the highest scoring
AGREE II domains of clarity of presentation, and scope and purpose [13, 30], as they appeared
to have been developed with specific purposes, end-users, needs and care settings in mind.
These Tier 3 products would potentially be of interest to other resourced-constrained environ-
ments with similar PHC implementation challenges. However, without underpinning Tiers 1
Fig 3. Checklist for classification of guidance documents.
https://doi.org/10.1371/journal.pone.0195025.g003
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and 2 (Fig 2), Tier 3 documents have little credibility. To ensure credibility of Tier 3 docu-
ments, Tier 1 information should be appropriately referenced, and a summary should be avail-
able of the Tier 2 processes.
In order to facilitate standard classification of, and terminology in, clinical guidance docu-
ments, and to maintain standard reporting practices that meet international requirements for
CPG credibility, we developed a checklist to assist CPG writers in resource-constrained envi-
ronments to identify in which category their guidance document belongs, as well as the
requirements for each category (Fig 3). We also produced a glossary of common terms and
explanations to assist CPG writers in resource-constrained environments (See S3 Appendix).
Our model and the checklist require further testing to confirm its validity, and to test its rele-
vance and utility in other environments which are not sufficiently resourced to efficiently inde-
pendently develop Tier 1 evidence.
Conclusion
This research demonstrated that the quality of SA PHC CPGs could be readily improved by
using available high quality CPGs, referencing them appropriately, and focusing scant
resources on local implementation. We believe that our three-tiered theoretical model (includ-
ing proposed Tier 3 nomenclature), checklist and glossary of terms presents a novel resource
to underpin efficient high-quality CPG writing activities in resource-constrained environ-
ments, and where there is an urgent need for best-evidence implementation to improve local
healthcare processes and outcomes. We have confidence that these resources have relevance
worldwide, particularly in situations where limited resources could be better spent on putting
available evidence into effective practice, and not on ‘recreating’ an already existing evidence-
base.
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